Peer-reviewedCC BY-NC-NDMetabolism open
Cardiometabolic medicine in China: Burden, challenges, and strategic priorities
- 1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China
- 2Cardiometabolic Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China
Related
- Advocacy and policy leadership training for primary care: a global environmental scan of competency frameworks, interventions, and strategic priorities
- A modified Delphi study to determine Australian healthcare consumer priorities and consensus for the use of genomics and precision medicine approaches in pregnancy healthcare and research
- Advancing Perioperative Medicine With AI: Current Landscape and Research Priorities.
- Treatment burden and cardiometabolic multimorbidity: Implications for the Philippines
- Concomitant Hypodontia and Hyperdontia (CHH): Clinical Challenges and Public Health Strategic Importance in Saudi Arabia.
BibTeX
@article{zeng2026cardiometabolic,
title = {{Cardiometabolic medicine in China: Burden, challenges, and strategic priorities}},
author = {Rui-Xiang Zeng and Sha Li and Xiao Wang and Ke-Fei Dou and Jian-Jun Li},
journal = {Metabolism open},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13672827},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Cardiometabolic medicine in China: Burden, challenges, and strategic priorities
AU - Rui-Xiang Zeng
AU - Sha Li
AU - Xiao Wang
AU - Ke-Fei Dou
AU - Jian-Jun Li
PY - 2026
DA - 2026/10/05
JO - Metabolism open
UR - https://europepmc.org/article/PMC/PMC13672827
SN - 2589-9368
ER -